ERBB2 and breast cancer: Lack of SphK1 causes a decrease in expression of claudin-2 in HER2/neu-induced breast tumors as well as reduction in overall tumor development. Increased SphK1 expression promoted cancerous cellular functions in the same breast cancer cells